Please login to the form below

Not currently logged in
Email:
Password:

This Month

This page shows the latest This Month news and features for those working in and with pharma, biotech and healthcare.

Sanofi sells European generics to Advent for $2.4bn

Sanofi sells European generics to Advent for $2.4bn

Sanofi has been looking to divest the Zentiva generics unit since 2016 as part of restructuring the business under chief executive Olivier Brandicourt, who said: “Transferring this business to Advent is ... Just this month, for example, GlaxoSmithKline

Latest news

More from news
Approximately 19 fully matching, plus 580 partially matching documents found.

Latest Intelligence

  • Digital health Digital health

    Companies that embrace this fast and hard will access better outcomes and improve population management.”. ... The solution, which combines tools based in cognitive behavioural theory, mindfulness, optimism and gratitude is firmly grounded in

  • Ten years at the forefront of patient experience Ten years at the forefront of patient experience

    Ten years at the forefront of patient experience. This month marks ten years of Hive, which has prompted us to reflect on how the world has changed over the last decade, ... in the future; the fact that the phrase ‘customer experience (CX) ’has

  • Deal Watch January 2018

    Three companies have been particularly active in deal making this month: Sanofi, Celgene and Takeda - more on this below. ... Celgene back in acquisition mode. While Sanofi led the way with a committed spend of $16.4bn in January, Celgene also had a

  • Pfizer and IBM's tech-enabled 'Parkinson’s house' Pfizer and IBM's tech-enabled 'Parkinson’s house'

    But this elegant home, surrounded by manicured lawns, is wired to beat the scourge of Parkinson’s disease. ... This is a turning point for Parkinson’s.”. The success of BlueSky is important for both companies.

  • Flight path: the long-haul journey Flight path: the long-haul journey

    This complexity often leads to half-hearted planning exercises with limited buy-in of the executing teams. ... This in turn means that strategic plans can become static, sluggish and ultimately unsuccessful.

More from intelligence
Approximately 0 fully matching, plus 101 partially matching documents found.

Latest appointments

  • Dr Paula Salmikangas joins NDA Group Dr Paula Salmikangas joins NDA Group

    Dr Salmikangas is the second recent senior appointment at NDA Group following the appointment of Dr Van den Eynde, who joined earlier this month as its new vice president.

  • Maxor appoints new chief executive officer Maxor appoints new chief executive officer

    Maxor National Pharmacy Services has appointed Mike Ellis as its new chief executive officer, replacing John Ward who retired earlier this month. ... He established a strong culture at the Company and contributed meaningfully to Maxor's significant

  • Quantum Pharma promotes Chris Rigg to chief financial officer Quantum Pharma promotes Chris Rigg to chief financial officer

    Durham, UK-based Quantum Pharma has promoted Chris Rigg from group strategic director to chief financial officer and board member following the resignation of Martin Such earlier this month.

  • Dr Holger Adelmann joins DIA EMEA Dr Holger Adelmann joins DIA EMEA

    care community to this rapidly evolving region.”. ... Dr Adlemann succeeds Dr Jytte Lynvig who retired from the post earlier this month.

  • Boehringer Ingelheim's John Pugh set for move to Accenture Boehringer Ingelheim's John Pugh set for move to Accenture

    Boehringer Ingelheim's global innovation team leader John Pugh is leaving the German pharmaceutical company at the end of this month to join Accenture. ... During this time Pugh was responsible for setting up and operating the company's acclaimed social

More from appointments
Approximately 0 fully matching, plus 16 partially matching documents found.

Latest from PMHub

  • Increasing the speed of knowledge sharing in blood cancer to improve patient care

    The latter half of the month is focused on Myeloma, as this week we head across the Atlantic to Boston, USA and  Myeloma 2016 and then back to Europe for Controversies ... patients. However, the compact April congress calendar highlights the significant

  • Beyond Andrology: Trends in Men’s Health in Emerging Markets

    This month, I turn my attention to men’ s health and look at how men in emerging markets face a different set of health challenges, again influenced in large part by

  • Latest wave of Therapy Watch IBD to run this month

    Latest wave of Therapy Watch IBD to run this month. The IBD syndicated market tracker is part of our large auto-immune portfolio. ... This month, Therapy Watch IBD will be running in the 5 EU markets of France, Germany, Italy, Spain and the UK.

  • Research Partnership

    Earlier this month, Directors Tom Nolte and Melinda Shorr attended the Pharmaceutical Market Research Conference in Newark, New Jersey. ... This month Mary Assimakopoulos examines some of the insights gathered while surveying 2, 000 patients suffering

More from PMHub
Approximately 0 fully matching, plus 4 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
90TEN Healthcare

90TEN is an award-winning healthcare communications consultancy that puts people at the heart of everything we do. Our Life.Changing. campaigns...

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...

Infographics